Leptin gene transfer in the hypothalamus enhances longevity in adult monogenic mutant mice in the absence of circulating leptin

被引:29
作者
Boghossian, Stephane
Ueno, Naohiko
Dube, Michael G.
Kalra, Pushpa
Kalra, Satya
机构
[1] Univ Florida, McKnight Brain Inst, Dept Neurosci, Gainesville, FL 32610 USA
[2] Dept Physiol & Funct Genom, Gainesville, FL USA
基金
美国国家卫生研究院;
关键词
leptin gene therapy; longevity; fat; hypothalamus;
D O I
10.1016/j.neurobiolaging.2006.08.010
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Leptin, a product of the ob gene, is a pleiotropic signal implicated in regulation of multiple physiological functions in the periphery and centrally, including hypothalamic integration of energy homeostasis. Recessive mutations of ob gene result in early onset of hyperphagia, morbid obesity, metabolic disorders, early mortality and shortened life-span. Intracerebroventricular injection of recombinant adeno-associated virus vector (rAAV) encoding the leptin gene in adult obese oblob mice enhanced leptin transgene expression only in the hypothalamus, normalized food intake, body weight and more than doubled the life-span as compared to control cohorts and extended it to near that of normal wild type mice. These life-extending benefits were associated with drastic reductions in visceral fat, and blood glucose and insulin levels, but elevated ghrelin levels, the anti-aging biomarkers. Thus, bioavailability of leptin transduced by ectopic gene in the hypothalamus alone is both necessary and sufficient to normalize life-span. Evidently, site-specific ectopic gene expression with rAAV is durable and safe for alleviating neural disorders that stem from missing or functional disruption of a single gene. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1594 / 1604
页数:11
相关论文
共 67 条
[1]   Peripheral signals set the tone for central regulation of metabolism [J].
Alquier, T ;
Kahn, BB .
ENDOCRINOLOGY, 2004, 145 (09) :4022-4024
[2]   Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function [J].
Arvanitakis, Z ;
Wilson, RS ;
Bienias, JL ;
Evans, DA ;
Bennett, DA .
ARCHIVES OF NEUROLOGY, 2004, 61 (05) :661-666
[3]   The stomach is a source of leptin [J].
Bado, A ;
Levasseur, S ;
Attoub, S ;
Kermorgant, S ;
Laigneau, JP ;
Bortoluzzi, MN ;
Moizo, L ;
Lehy, T ;
Guerre-Millo, M ;
Le Marchand-Brustel, Y ;
Lewin, MJM .
NATURE, 1998, 394 (6695) :790-793
[4]   Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy [J].
Bagnasco, M ;
Dube, MG ;
Kalra, PS ;
Kalra, SP .
ENDOCRINOLOGY, 2002, 143 (11) :4409-4421
[5]   Leptin expression in hypothalamic PVN reverses dietary obesity and hyperinsulinemia but stimulates ghrelin [J].
Bagnasco, M ;
Dube, MG ;
Katz, A ;
Kalra, PS ;
Kalra, SP .
OBESITY RESEARCH, 2003, 11 (12) :1463-1470
[6]   The genetics of human obesity [J].
Bell, CG ;
Walley, AJ ;
Froguel, P .
NATURE REVIEWS GENETICS, 2005, 6 (03) :221-234
[7]   Central LIF gene therapy suppresses food intake, body weight, serum leptin and insulin for extended periods [J].
Beretta, E ;
Dhillon, H ;
Kalra, PS ;
Kalra, SP .
PEPTIDES, 2002, 23 (05) :975-984
[8]  
Beretta E, 2002, PEDIATR RES, V52, DOI [10.1203/01.PDR.0000023496.70201.8E, 10.1203/00006450-200208000-00010]
[9]   Extended longevity in mice lacking the insulin receptor in adipose tissue [J].
Blüher, M ;
Kahn, BB ;
Kahn, CR .
SCIENCE, 2003, 299 (5606) :572-574
[10]   Suppression of fat deposition for the life time with gene therapy [J].
Boghossian, S ;
Lecklin, A ;
Torto, R ;
Kalra, PS ;
Kalra, SP .
PEPTIDES, 2005, 26 (08) :1512-1519